Mayo CRM-original iPSC-derived islet product in a retrievable, encapsulation device
Grant Project Details:
Our product is MC-iLETS01, Mayo Center for Regenerative Medicine-original iPSC-derived islet cell product in a retrievable encapsulation device, for diabetes therapy. We will test its long-term safety/functionality in a mouse model of diabetes. The data will be used for our FDA pre-IND and IND applications.